2
MED-EL Launches World's First Commercially Available Totally Invisible Cochlear Implant
mehr
Meldungen zum Thema Medizin
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal partners with DKSH to bring four important pain medicines to eight new markets in Asia-Pacific
Aachen, Germany (ots) - - The partnership will bring Qutenza®, Vimovo®, Palexia® and Zomig® to people living with pain in Asia-Pacific, spanning Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand and Vietnam. - Pain is a significant healthcare challenge in the region, due to the ageing ...
mehrGrünenthal acquires cancer treatment Stivarga®
Aachen (ots) - - Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. - Stivarga® (regorafenib) is an established oral treatment for certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer). It is approved ...
mehriuvando Health and Immatics collaborate to improve access to clinical trials for patients with metastatic melanoma
Mannheim (ots) - iuvando Health, a leading health tech company specializing in clinical trials matching and physician-led patient navigation support, today announced its collaboration with Immatics, the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and ...
mehrGrünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich
Aachen, Germany (ots) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic ...
mehrPromising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity
Tübingen (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its completed Phase 2a PROHEAR Study. ACOU085 is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across ...
mehr
The Virchow Prize 2026 Awarded for Pioneering Work on Ebola, Advancing Global Epidemic Preparedness and Fostering Global Solidarity
mehrLTS Lohmann Therapie-Systeme AG
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...
mehrVITUS Privatklinik Prof. Dr. Stehling GmbH
First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response
OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...
mehrFUTRUE Neurosciences Reaches Major Milestone
mehrGrünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm
Aachen, Germany & Yeoju, South Korea (ots) - Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will ...
mehr- 3
Medi-Globe Launches mAI Companion® - the World’s First Real‑Time AI Assistant for Pancreatic EUS, Co‑Developed with IHU Strasbourg / Now MDR CE‑Marked and Available for Clinical Use in Europe
mehr
Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development
Aachen, Germany (ots) - Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in ...
mehrServier delivers solid performance in 2024/25 and confirms its forecasts for 2030
Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...
mehrORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner / Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
mehr30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength
mehrDeutsche Gesellschaft für Chirotherapie und Osteopathie e. V.
Internationally honored: Prof. Dietmar Jürgen Daichendt receives honorary doctorate for pioneering achievements in osteopathy and manual medicine
mehrAsklepios Kliniken GmbH & Co. KGaA
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award
Wiesbaden, Germany (ots) - - Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy - One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time - Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical ...
mehr
European Society for Medical Oncology (ESMO)
ESMO releases first-ever guidance for safe use of AI Language Models in cancer care
mehrAsklepios Kliniken GmbH & Co. KGaA
2Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
mehrInstitut für Plastination e. K.
1230 Years of BODY WORLDS / A Success Story That Has Changed the Way We See Ourselves
mehrServier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
mehrAsklepios Kliniken GmbH & Co. KGaA
Nominations for the Broermann Medical Innovation Award 2026 now open
Hamburg (ots) - - With a million euros, it is one of the world’s most highly endowed awards for medical research The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made ...
mehrGrünenthal PRO is joining SHL Medical’s alliance partnership network to offer final assembly service for Molly® autoinjectors
Aachen (ots) - Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery ...
mehr
Cannovum Health welcomes new strategic majority investor – Triple Crown Ventures becomes main shareholder
mehrCroma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
mehrSingapore-Based Innovative Biomedical Start-Up Achieves “Strategic Triumph“ to Conquer Chinese Med-Tech Market
Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the company’s history; product approval in China was the company’s ...
mehrWorld Health Summit 2025: Registration Open - First High-Level Speakers Announced
Berlin (ots) - Registration for the World Health Summit 2025 is now open. From October 12-14, Berlin will once again host one of the most important strategic global health gatherings worldwide. Under the theme "Taking Responsibility for Health in a Fragmenting World", the summit brings together leading minds from academia, politics, the private sector, and civil ...
mehrIntuitive Surgical Deutschland GmbH
Intuitive’s da Vinci 5 Surgical System Receives CE Mark / Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
mehrx-cardiac and Hemedic Partner to Bring AI-Based Medical Devices to ICUs Across Scandinavia
Berlin/Copenhagen (ots) - x-cardiac GmbH, a leading provider of AI-based health solutions and a spin-off of the German Heart Center of Charité and Charité - Universitätsmedizin Berlin, announced today a strategic distribution partnership with the Danish company Hemedic ApS to expand the reach of its AI-based medical devices in Scandinavia. Through this partnership, ...
mehr
123456Nächste